United States recommends halt Johnson's vaccination After

[limited]

The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) released a joint statement today. Recommends US Curbing COVID-19 Vaccination Of the Johnson & Johnson Company (J&J) on a temporary basis. Meanwhile, both agencies are investigating cases of potentially dangerous thromboembolism in six women receiving the Johnson & Johnson vaccine.
The statement said Federal vaccine distribution channels Including large vaccination locations It will suspend use of Johnson & Johnson's slotxo vaccine and it is expected that states As well as other vaccination providers Will follow the same

So far, more than 6.8 million doses of Johnson & Johnson have been vaccinated in the United States.

The CDC's Immunization Advisory Committee will meet on Wednesday. To discuss cases of reported cases of thromboembolism following J&J vaccination, the FDA will also begin investigating the case.

"Until the process is finished We recommend that this vaccine be temporarily discontinued due to a wide range of precautions, ”said Dr. Anchuchat, CDC Deputy Director General and Peter Mark, director of the Center for Biological Drug Evaluation and Research. object Stated in the joint statement

The statement said six women who had thromboembolism after getting the vaccine were between the ages of 18-48, with symptoms 6-13 days after receiving the vaccine. One woman died. A second woman in Nebraska was hospitalized in critical condition.

The move came less than a week after the European Medicines Agency (EMA) said it was investigating cases of thromboembolism in people vaccinated with John. Johnson & Johnson in the United States

On Friday, April 9, the EMA released an investigation into four cases of COVID-19 infected with thromboembolism after receiving the COVID-19 vaccine. Of Johnson & Johnson Company

A statement from the EMA said the safety committee had begun assessing thromboembolic cases. Which arises from coagulation of blood clots And resulting in clogged arteries in those receiving the vaccine.

The EMA revealed that the link between Johnson & Johnson's vaccine and the condition was unclear. The safety committee decides whether regulatory action is necessary, such as changing the label.

Johnson & Johnson's single-dose vaccine is currently approved for emergency use in the United States. And it was approved in the European Union (EU) last March. But no member country has yet started using the vaccine.